The Motley Fool

WM Morrison plc, BP plc, BHP Billiton plc, GlaxoSmithKline plc and Centrica PLC Can Cure Your Tesco Dividend Cut Blues

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When a former dividend hero like Tesco scraps its final payout of the year, it’s enough to give grown investors the blues.

Especially when that comes on top of a previous 75% cut in its dividend payout.

5 Stocks For Trying To Build Wealth After 50

Markets around the world are reeling from the coronavirus pandemic… and with so many great companies trading at what look to be ‘discount-bin’ prices, now could be the time for savvy investors to snap up some potential bargains.

But whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times.

Fortunately, The Motley Fool UK analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global upheaval…

We’re sharing the names in a special FREE investing report that you can download today. And if you’re 50 or over, we believe these stocks could be a great fit for any well-diversified portfolio.

Click here to claim your free copy now!

Wipe your tears, income seekers, because there are plenty more fish swimming in this particular sea. The FTSE 100 is positively teeming with big fat juicy dividends just waiting to be snapped up.

And plenty of them are yielding far more than Tesco ever did.

WM Morrison

If you reckon the supermarket sector is ripe for a recovery, you may be tempted by WM Morrison (LSE: MRW).

Its share price leapt more than 7% on Thursday, largely on the coattails of rivals Tesco and Sainsbury’s, whose Christmases weren’t the disaster everybody expected.

Normally I wouldn’t touch a company yielding 7.4% on the assumption that it would be unsustainable, but management surprised everybody last year by promising further progression.

At 6.8 times earnings, Morrisons isn’t expensive, either, especially with consumer spending power finally set to rise in real terms this year.

Morrisons is risky, but that’s in the price.

BP

Oil giant BP (LSE: BP) is also risky, with Brent crude shading $50 a barrel and the company’s tie-up with Kremlin-controlled Rosneft under the sanctions cosh.

BP’s share price is down more than 20% in the last six months but that leaves it cheap at just 4.8 times earnings, with a gushing 5.73% yield.

If you think we still can’t live without black gold, now is the ultimate contrarian buying opportunity.

BHP Billiton

You could say the same about mining giant BHP Billiton (LSE: BLT), as we near the end of the commodity super-cycle.

Even if we are, its 5.23% yield should provide some solace. And with the share price down nearly one-third in the last six months, you aren’t overpaying at 7.79 times earnings.

Especially if the commodity shake-up wipes out its smaller rivals.

GlaxoSmithKline And Centrica

We also have troubled GlaxoSmithKline (LSE: GSK) on a meaty 5.46% yield and British Gas owner Centrica (LSE: CNA) on a mind-boggling 6.27%. Both stocks are down around 12% in the last six months.

Glaxo faces a battle to restore its tarnished reputation, but could prove a strong defensive hold in what may be a turbulent year.

Centrica is set to be a political football with high utility bills to feature heavily in the forthcoming election, although a mild winter and recent energy price falls may take some heat out of the debate. That yield is enough to cure your blues until it is all over.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Harvey Jones has no position in any shares mentioned. The Motley Fool UK has recommended Centrica and GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.